Literature DB >> 1999275

Frequency and effects of apolipoprotein E polymorphism in Mexican-American NIDDM subjects.

M D Shriver1, E Boerwinkle, D Hewett-Emmett, C L Hanis.   

Abstract

We typed 254 non-insulin-dependent diabetic (NIDDM) Mexican Americans living in Starr County, Texas, for the three common apolipoprotein E (apoE) alleles. Typing was performed via DNA amplification and Hha I restriction. The allele frequencies (epsilon 2 = 0.041, epsilon 3 = 0.860, epsilon 4 = 0.099) were in Hardy-Weinberg equilibrium (chi 2 = 0.60, df = 3) and did not differ from a random sample from the same population (chi 2 = 0.16, df = 2). Analysis of variance was used to test for mean differences in lipid, lipoprotein, and glucose levels among apoE types. Significant differences among types were detected for low-density lipoprotein cholesterol (LDL-chol; P = 0.042, R2 = 2.6) and beta-lipoprotein cholesterol (P = 0.019, R2 = 3.3) levels. Mean LDL-chol in E2/3 individuals was 2.69 mM, E3/3 was 3.26 mM, and E4/3 was 3.36 mM. Mean beta-lipoprotein cholesterol in E2/3 individuals was 3.05 mM, E3/3 was 3.64 mM, and E4/3 was 3.67 mM. Based on these results, we conclude that the effects of the apoE polymorphism on lipid profiles and glucose levels are the same in NIDDM subjects as in nondiabetic Mexican Americans and other populations. Other studies investigating the role of apoE polymorphism in diabetic subjects have found increased triglyceride levels in individuals possessing an epsilon 2-allele and an increased frequency of the epsilon 2-allele in hyperlipidemic diabetic subjects. We found no significant difference in mean triglyceride levels among genotypes. Possible reasons for this discrepancy are discussed, including DNA- versus protein-typing methods.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1999275     DOI: 10.2337/diab.40.3.334

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.

Authors:  Jessica B S Langbaum; Kewei Chen; Richard J Caselli; Wendy Lee; Cole Reschke; Daniel Bandy; Gene E Alexander; Christine M Burns; Alfred W Kaszniak; Stephanie A Reeder; Jason J Corneveaux; April N Allen; Jeremy Pruzin; Matthew J Huentelman; Adam S Fleisher; Eric M Reiman
Journal:  Arch Neurol       Date:  2010-04

2.  Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies.

Authors:  M Boemi; R W James; F Romagnoli; P Gerber; D Pometta; P Fumelli
Journal:  Diabetologia       Date:  1993-03       Impact factor: 10.122

3.  Rapid and safe determination of human apolipoprotein E genotypes by miniaturised SDS-PAGE in non-insulin dependent diabetes mellitus.

Authors:  C Clavel; A Durlach; V Durlach; P Birembaut
Journal:  J Clin Pathol       Date:  1995-04       Impact factor: 3.411

4.  The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations.

Authors:  D M Hallman; E Boerwinkle; N Saha; C Sandholzer; H J Menzel; A Csázár; G Utermann
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

5.  Differential modulation of diet-induced obesity and adipocyte functionality by human apolipoprotein E3 and E4 in mice.

Authors:  J M Arbones-Mainar; L A Johnson; M K Altenburg; N Maeda
Journal:  Int J Obes (Lond)       Date:  2008-08-26       Impact factor: 5.095

6.  Dementia and diabetes mellitus: association with apolipoprotein e4 polymorphism from a hospital in southern India.

Authors:  Lakshmi Narayanan Kota; Bhagyalakshmi Mallapura Shankarappa; Prafulla Shivakumar; Shilpa Sadanand; Bhavani Shankara Bagepally; Srinivas Brahmadevarahalli Krishnappa; Meera Purushottam; Palanimuthu Thangaraju Sivakumar; Sanjeev Jain; Mathew Varghese; Srikala Bharath
Journal:  Int J Alzheimers Dis       Date:  2012-06-03

7.  Association of APOE polymorphism with chronic kidney disease in a nationally representative sample: a Third National Health and Nutrition Examination Survey (NHANES III) Genetic Study.

Authors:  Audrey Y Chu; Rulan S Parekh; Brad C Astor; Josef Coresh; Yvette Berthier-Schaad; Michael W Smith; Alan R Shuldiner; Wen Hong L Kao
Journal:  BMC Med Genet       Date:  2009-10-23       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.